Photo Galleries

(Image: Getty/Metamorworks)

Hired and Retired: In with the new

By Ben Hargreaves

A number of companies spent the early part of the year creating and then filling new positions, which has seen another big pharma company follow the trend of appointing a chief digital officer.

Pharma appointments create controversy

Hired and Retired: Controversies at the top

By Ben Hargreaves

The new year has led to a new look to executive boards across the pharma industry, but the movement has arrived with a degree of intrigue in some cases.

(Image: Getty/marchmeena29)

Hired and Retired: Summer Edition

By Ben Hargreaves

in-PharmaTechnologist gives you an overview of some of the notable hires that have taken place in the last month.

iStock/bee32

Hired while you were on holiday: pharma appointments

By Flora Southey

Novartis announces a new CEO, the MHRA re-appoints its chair, Paul Smith to lead BioAscent Discovery, and MedPharm welcomes Simon Redgrove and Jeremy Drummond.In-PharmaTechnologist catches you up on recent pharma hires.

iStock/BartekSzewczyk

Pharma executives make a move: recent appointments

By Flora Southey

Ocugen welcomes ex-Pfizer Daniel Jorgensen, the IGBMA’s Biosimilars Committee gets a new chair and drug development consultants Boyds hires two associate directors in one go.

Hiring and Firing Feb '17

People on the Move

Hiring and Firing Feb '17

By Dani Bancroft

in-PharmaTechnologist presents this month's roundup of who is moving where in the Pharma industry.

Hiring and Firing Jan '17

PEOPLE ON THE MOVE

Hiring and Firing Jan '17

By Dani Bancroft

Welcome to in-PharmaTechnologist's monthly round up of who's been moving where in the small-molecule manufacturing world. The CEO of BMS is moving internally, Axim Biotechnologies and Pharmalink have new board members, whilst Vium and Dova Pharmaceuticals...

The SpaceX Dragon spacecraft nears the International Space Station during the CRS-8 mission to deliver experiments and supplies to the International Space Station. (Image credit: NASA)

Dispatches from BIO 2016

Drug development in space: how microgravity enables pharma

By Melissa Fassbender

Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the next year – with several implications for pharma back on Earth.